Clinical, Histopathological and Molecular Characteristics of Metastatic Breast Cancer in North-Eastern Kazakhstan: a 10 Year Retrospective Study
- PMID: 28013536
- PMCID: PMC5454634
- DOI: 10.22034/apjcp.2016.17.10.4797
Clinical, Histopathological and Molecular Characteristics of Metastatic Breast Cancer in North-Eastern Kazakhstan: a 10 Year Retrospective Study
Abstract
Background: Breast cancer (BC) is the top cancer among women worldwide and has been the most frequent malignancy among Kazakhstan women over the past few decades. Information on clinical and histopathological features of metastatic breast cancer (MBC), as well as the distribution of molecular subtypes is limited for Kazakh people. Materials and Methods: The present observational retrospective study was carried out at Regional Oncologic Dispensaries in the North-East Region of Kazakhstan (in Semey and Pavlodar cities). Сlinical and histopathological data were obtained for a total of 570 MBC patients in the 10 year period from 2004-2013, for whom data on molecular subtype were available for 253. Data from hospital charts were entered into SPSS 20 for analysis by one-way ANOVA analysis of associations of different variables with 1-5 year survival. Pearson correlation and linear regression models were used to examine the relation between parameters with a p-value < 0.05 considered statistically significant. Results: No significant relationships were evident between molecular subtype and survival, site of metastases, stage or ethnicity. Young females below the age of 44 were slightly more likely to have triple negative lesions. While the ductal type greatly predomonated, luminal A and B cases had a higher percentage with lobular morphology. Conclusions: In this select group of metastatice brease cancer, no links were noted for survival with molecular subtype, in contrast to much of the literature.
Keywords: Breast cancer; molecular subtypes; mortality; metastasis; North-East Kazakhstan.
Figures
Similar articles
-
First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.BMC Womens Health. 2017 Jan 9;17(1):3. doi: 10.1186/s12905-016-0361-z. BMC Womens Health. 2017. PMID: 28068979 Free PMC article.
-
The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.J BUON. 2016 Nov-Dec;21(6):1410-1418. J BUON. 2016. PMID: 28039701
-
[Clinicopathological characteristics and prognosis of different molecular types of breast cancer].Zhonghua Yi Xue Za Zhi. 2016 Jun 14;96(22):1733-7. doi: 10.3760/cma.j.issn.0376-2491.2016.22.004. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27356638 Chinese.
-
Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.Pathol Oncol Res. 2015 Jul;21(3):553-61. doi: 10.1007/s12253-015-9944-5. Epub 2015 May 12. Pathol Oncol Res. 2015. PMID: 25962349 Review.
-
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.Clin Breast Cancer. 2017 Aug;17(5):382-391. doi: 10.1016/j.clbc.2017.04.009. Epub 2017 Apr 26. Clin Breast Cancer. 2017. PMID: 28529029 Free PMC article. Review.
Cited by
-
Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study.Breast Cancer Res. 2020 Oct 27;22(1):114. doi: 10.1186/s13058-020-01349-9. Breast Cancer Res. 2020. PMID: 33109210 Free PMC article. Clinical Trial.
-
The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer.Breast Dis. 2024;43(1):71-78. doi: 10.3233/BD-249000. Breast Dis. 2024. PMID: 38669518 Free PMC article.
-
Analysis of Delays in Breast Cancer Treatment and Late-Stage Diagnosis in Kazakhstan.Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2519-2525. doi: 10.22034/APJCP.2018.19.9.2519. Asian Pac J Cancer Prev. 2018. PMID: 30256046 Free PMC article.
-
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal.Breast Cancer (Dove Med Press). 2022 Aug 26;14:229-246. doi: 10.2147/BCTT.S366530. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 36052152 Free PMC article.
References
-
- Bekmukhambetov Y, Imangazina Z, Jarkenov T, et al. Cancer incidence and mortality data in Aktobe, West Kazakhstan, 2000-2010. Asian Pac J Cancer Prev. 2015;16:2379–83. - PubMed
-
- Beysebayev E, Bilyalova Z, Kozhakeeva L, Baissalbayeva A, Abiltayeva A. Spatial and temporal epidemiological assessment of breast cancer incidence and mortality in Kazakhstan, 1999-2013. Asian Pac J Cancer Prev. 2015a;16:6795. - PubMed
-
- Beysebayev E, Tulebayev K, Meymanalyev T. Breast. 2015b - PubMed
-
- cancer diagnosis by mammography in Kazakhstan - staging results of breast cancer with double reading. Asian Pac J Cancer Prev. 13:2341–4. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous